Navigation Links
NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
Date:5/16/2012

GLOW2 was a 52-week double-blind, placebo-controlled, parallel-group study involving 1,066 patients to assess the efficacy, safety and tolerability of NVA237 in patients with COPD. Patients were randomized into three treatment arms receiving either once-daily NVA237 50 mcg or placebo (double-blind), or once-daily OL tiotropium 18 mcg. They were also permitted to use COPD background therapy and rescue medication.

Phase II clinical trial update

Results have recently been submitted for publication from the NVA237 Phase II A2208 study. This study comparing once-daily and twice-daily dosing regimens of NVA237 met its primary endpoint by demonstrating that all treatments (12.5 mcg, 25 mcg and 50 mcg given once or twice daily and 100 mcg once daily) provided statistically significant bronchodilation over the course of the day (measured by mean trough FEV1 at Day 28) in patients with moderate-to-severe COPD compared to placebo.

Differences in lung function (measured by FEV1 AUC0-24h)between a single daily dose of NVA237 and the same total amount given twice daily were small and not clinically relevant. However once-daily dosing is known to offer the potential to improve patient adherence, an important consideration when selecting the optimum dosing regimen for a novel bronchodilator. Throughout the study, NVA237 showed an overall good safety profile and was well tolerated compared to placebo. The results of A2208 are consistent with previous NVA237 studies and support once-daily dosing of 50 mcg NVA237 in patients with moderate-to-severe COPD.

Notes for editors:

NVA237 (glycopyrronium bromide. Seebri® Breezhaler®) is an investigational long-acting muscarinic antagonist (LAMA) developed as a once-daily inhaled maintenance therapy for the treatment of COPD. Phase III data from the GLOW 1, 2 and 3 studies demonstrated that NVA237 increased patients' lung function o
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
2. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
3. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
4. NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
5. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
6. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
7. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
9. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
10. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015  Mail-service and specialty pharmacies will save ... government health plans $11.8 billion over the next ... Care Management Association (PCMA). "Home delivery ... the easiest ways to reduce health costs," said ... "Policymakers should resist efforts to restrict these cost-saving ...
(Date:3/4/2015)... , March 4, 2015   Aratana Therapeutics, ... therapeutics company focused on the licensing, development and commercialization ... that it will present at the Barclays Global ... at the Loews Miami Beach Hotel in ... St. Peter , M.D., President and Chief Executive Officer ...
(Date:3/4/2015)... 4, 2015 Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer ... and cancer, today announced that James A. Joyce ... corporate overview at the 27th Annual ROTH Conference on ... Laguna Niguel, California . To learn more ... A live webcast of the presentation will ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2
... 9, 2012 BASIS Science, Inc. ( www.mybasis.com ) the ... tracker, the Basis™ B1 band, will be demoing at the ... web-based personal dashboard for the first time. The dashboard has ... about their everyday health and wellness. "We have ...
... Jan. 9, 2012  The National Association of ... that facilitates cooperation between law enforcement, healthcare ... in the prevention and investigation of drug ... Precursor Log Exchange (NPLEx) in Kentucky is ...
Cached Medicine Technology:BASIS Science to Demo Basis Band at 2012 International CES; Reveals Design of Web Dashboard 2Kentucky Real-Time, Stop-Sale System Is Effective In Blocking Illegal Sales Of Pseudoephedrine 2
(Date:3/4/2015)... March 04, 2015 The Conrad N. ... a total of $6.9 million, which will help 151,000 ... and Burkina Faso. , The programs cover three years ... will focus on fixing water points in disrepair, addressing ... local people to maintain water points and ensuring safe ...
(Date:3/4/2015)... San Francisco, CA (PRWEB) March 04, 2015 ... Analytics solutions have been selected by Chase Brexton ... the company announced today. , Chase Brexton provides ... to more than 30,000 patients across seven clinics ... As early adopters of electronic medical records, the ...
(Date:3/4/2015)... March 04, 2015 Nike Swim Camps ... staff whose mission is to stimulate a love of ... Swim Camps provide campers the opportunity to train with ... says Paul Merrion, Vice President of US Sports Camps. ... each swimmer to build confidence and improve their technique.” ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... by the increasing incidence of CNS disorders, aging population, ... stage drugs. The unmet medical needs for diagnosing and ... in the market. Presently, there exists an urgent need ... limitations of current generation drugs. Companies are therefore investing ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Nitrosigine®, a ... ingredient in premium sports nutrition products, is hosting the ... booth in the Terrace Ballroom at The Arnold Sports ... March 5, 2015 to March 8, 2015. , ... with FDA New Dietary Ingredient notification status; now affirmed ...
Breaking Medicine News(10 mins):Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3
... , , , ... successful payment strategies enables the North American home healthcare and ... digit growth in the traditionally mature patient monitoring space. The ... is the increasing incidence of cardiovascular disease (CD) in the ...
... , NEW YORK, Aug. 14 More men than ... more than tripled since 2001. In the past, there was a ... society men seeking to improve their looks in a very competitive ... men. The most commonly treated area in men is the frown ...
... YORK, Aug. 14 MGT Capital Investments, Inc. (NYSE AMEX: ... ended June 30, 2009 and provided an update on strategic milestones. ... equivalents and marketable securities were $31.0 million compared to $40.2 million at ... ended June 30, 2009, MGT,s total revenue was $47,000 compared to $85,000 ...
... 14 /PRNewswire-Asia/ --, -- CordLife to assist Beijing China ... with international AABB standards., -- Potential opportunity for Singaporeans ... their children,s cord blood stem cells back home to Singapore or to ... Leading private cord blood bank CordLife has gained ...
... ... Design team has been selected to do a feasibility study, plan and ... team includes Rees Associates, Inc., OMMA Healthcare, LLC and SYMX Corp. ... Hospital worth approximately $50 million in construction costs. Governor Liyel Imoke ...
... One in ... find holidays more stressful than they should be. A male,s biggest fear is missing ... Under 30s are the most stressed on holiday. , ... Cardiff, UK (PRWEB) August 14, 2009 -- New research from ...
Cached Medicine News:Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 2Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 3Health News:Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan 4Health News:MGT Capital Investments, Inc. Reports Fiscal 2009 Second Quarter Financial Results 2Health News:MGT Capital Investments, Inc. Reports Fiscal 2009 Second Quarter Financial Results 3Health News:CordLife Makes Headway into China 2Health News:CordLife Makes Headway into China 3Health News:CordLife Makes Headway into China 4Health News:CordLife Makes Headway into China 5Health News:International Design Team Selected for Nigerian Hospital 2Health News:Spain Has The 'Stress' Factor, According to Confused.com 2Health News:Spain Has The 'Stress' Factor, According to Confused.com 3
Eliminate preanalytical errors with automated QC module....
Measure SpO2 and tcpCO2 with a single sensor....
... an automated blood gas analysis system that ... the steps in the analytical process, improve ... The 1st automatic system consists of the ... FLEXQ automatic sample handling system. With 1st ...
... RAPID Reader - Portable RAPIDViewing Software., ,RAPID® ... Diagnostic System, which can be installed on a ... open Patient RAPID Report (PRR) videos created on ... save them, at home or on the go, ...
Medicine Products: